ATE411006T1 - Liposomale anordnung für die therapeutische und/oder diagnostische anwendung - Google Patents

Liposomale anordnung für die therapeutische und/oder diagnostische anwendung

Info

Publication number
ATE411006T1
ATE411006T1 AT05749164T AT05749164T ATE411006T1 AT E411006 T1 ATE411006 T1 AT E411006T1 AT 05749164 T AT05749164 T AT 05749164T AT 05749164 T AT05749164 T AT 05749164T AT E411006 T1 ATE411006 T1 AT E411006T1
Authority
AT
Austria
Prior art keywords
liposome
therapeutic
micellar
diagnostic use
active compound
Prior art date
Application number
AT05749164T
Other languages
English (en)
Inventor
Herve Tournier
Roland Hyacinthe
Michel Schneider
Original Assignee
Bracco Research Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Research Sa filed Critical Bracco Research Sa
Application granted granted Critical
Publication of ATE411006T1 publication Critical patent/ATE411006T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Manufacturing & Machinery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AT05749164T 2004-06-03 2005-05-31 Liposomale anordnung für die therapeutische und/oder diagnostische anwendung ATE411006T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04013141 2004-06-03

Publications (1)

Publication Number Publication Date
ATE411006T1 true ATE411006T1 (de) 2008-10-15

Family

ID=34925239

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05749164T ATE411006T1 (de) 2004-06-03 2005-05-31 Liposomale anordnung für die therapeutische und/oder diagnostische anwendung

Country Status (8)

Country Link
US (1) US7749485B2 (de)
EP (1) EP1750671B1 (de)
JP (1) JP4773430B2 (de)
CN (1) CN1960707B (de)
AT (1) ATE411006T1 (de)
DE (1) DE602005010424D1 (de)
ES (1) ES2313352T3 (de)
WO (1) WO2005117832A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
ES2372499T3 (es) 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
US20070154403A1 (en) * 2006-01-05 2007-07-05 Thomas Skold Oral, Pulmonary and Transmucosal Delivery Composition
US8114150B2 (en) * 2006-06-14 2012-02-14 Advanced Cardiovascular Systems, Inc. RGD peptide attached to bioabsorbable stents
CN101541308B (zh) * 2006-09-28 2012-02-01 哈达斯特医疗研究服务和开发有限公司 甘油磷脂用于关节润滑的用途
WO2009091531A2 (en) * 2008-01-16 2009-07-23 The General Hospital Corporation Uniform-sized, multi-drug carrying and photosensitive liposomes for advance drug delivery
EP2147684A1 (de) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Selektiv gegen Metallproteasen wirkende Diagnosemittel
US20110229565A1 (en) 2008-09-17 2011-09-22 Karp Jeffrey M Drug Delivery Composition Comprising a Self-Assembled Gelator
US9192685B2 (en) 2008-10-07 2015-11-24 Bracco Suisse S.A. Targeting construct comprising anti-polymer antibody and contrast/therapeutic agents binding to the same
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
JP2012521389A (ja) * 2009-03-25 2012-09-13 ノバルティス アーゲー 薬物及びｓｉＲＮＡを含有する医薬組成物
JP5491067B2 (ja) * 2009-05-08 2014-05-14 一雄 丸山 リポソーム、リポソームの製造方法、及び医薬組成物
WO2011046934A1 (en) * 2009-10-12 2011-04-21 Au Jessie L-S Methods and compositions for improved delivery, expression or activity of rna interference agents
GB0920304D0 (en) * 2009-11-20 2010-01-06 Medical Res Council Novel liposome nanoparticles for tumour magnetic resonance imaging
MX2012006450A (es) * 2009-12-10 2012-06-28 Merck Patent Gmbh Composicion farmaceutica que comprende oligopeptidos.
EP2582406B1 (de) 2010-06-17 2018-03-14 Yeda Research and Development Co. Ltd. Phosphatidylcholinliposomen als grenzschmierstoffe in wässrigen medien
WO2012030842A2 (en) 2010-09-03 2012-03-08 Academia Sinica Anti-c-met antibody and methods of use thereof
EP2618821A4 (de) 2010-09-24 2014-08-13 Brigham & Womens Hospital Nanostrukturierte gele zur kontrollierten freisetzung verkapselter mittel
CN102078624B (zh) * 2010-12-23 2012-07-25 华东理工大学 一种高效载钆脂质体制剂及其制备方法
CA2827643C (en) 2011-02-18 2019-05-07 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
AU2012266803B2 (en) * 2011-06-09 2017-02-02 Merck Patent Gmbh Treatment of cancers and metastases with suspensions of cilengitide in carrier
EP2773327A4 (de) 2011-11-02 2015-06-03 Univ California Neuprogrammierung von zelladhäsion
TWI568453B (zh) * 2011-11-22 2017-02-01 原創生醫股份有限公司 具有螯合型複合微胞之藥物載體及其應用
CN105102001B (zh) * 2012-08-28 2017-12-26 原创生医股份有限公司 含金属的复合微胞药物载体的触发释放方法
US8883705B2 (en) 2012-10-30 2014-11-11 The Clorox Company Cationic micelles with anionic polymeric counterions systems thereof
US8883706B2 (en) 2012-10-30 2014-11-11 The Clorox Company Anionic micelles with cationic polymeric counterions systems thereof
US8728454B1 (en) 2012-10-30 2014-05-20 The Clorox Company Cationic micelles with anionic polymeric counterions compositions thereof
EP2914235A4 (de) * 2012-10-30 2016-07-20 Clorox Co Kationische mizellen mit anionischen polymeren gegenionenzusammensetzungen, verfahren und systeme
US8765114B2 (en) 2012-10-30 2014-07-01 The Clorox Company Anionic micelles with cationic polymeric counterions methods thereof
US8728530B1 (en) 2012-10-30 2014-05-20 The Clorox Company Anionic micelles with cationic polymeric counterions compositions thereof
CN102973508A (zh) * 2012-10-31 2013-03-20 河南牧翔动物药业有限公司 一种复方黄芪多糖脂质体长效注射液及其制备方法
AU2016335846B2 (en) 2015-10-08 2019-04-04 The Brigham And Women's Hospital, Inc. Stabilized assembled nanostructures for delivery of encapsulated agents
PT3416622T (pt) 2016-02-15 2023-08-28 Kemin Ind Inc Lipossomas com carga positiva como transportadores de moléculas lipofílicas
CA3062885C (en) * 2016-05-06 2022-03-29 The Brigham And Women's Hospital, Inc. Self-assembled gels for controlled delivery of biologics and labile agents
US10568840B2 (en) 2016-05-06 2020-02-25 The Brigham And Women's Hospital, Inc. Self assembled gels for controlled delivery of encapsulated agents to cartilage
US11020410B2 (en) 2017-02-03 2021-06-01 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
EP3361276A1 (de) * 2017-02-14 2018-08-15 Koninklijke Philips N.V. Brückenelement für ein magnetresonanzuntersuchungssystem
JP7211974B2 (ja) 2017-05-08 2023-01-24 アリヴィオ セラピューティクス， インコーポレイテッド 増大した薬剤負荷および接着のためのナノ構造化ゲルの製剤
EA201790844A1 (ru) * 2017-05-15 2018-11-30 Деркач, Олег Вадимович Контрастное средство на основе аморфных или аморфно-кристаллических наночастиц оксидов или гидроксидов марганца для мрт исследований мозга
EP4223284A1 (de) 2017-08-22 2023-08-09 Moebius Medical Ltd. Liposomale formulierung zur gelenkschmierung
EP3813788A1 (de) * 2018-06-27 2021-05-05 Breath Therapeutics GmbH Pharmazeutische zusammensetzungen in lyophilisierter form
CN111450266A (zh) * 2020-03-30 2020-07-28 中国科学院大学宁波华美医院 靶向革兰氏阳性细菌的磁共振成像造影剂、制备和应用
EP4522178A1 (de) 2023-01-19 2025-03-19 Moebius Medical Ltd. Liposomale zusammensetzung mit langzeitwirkung zur behandlung von schmerzen bei gelenkerkrankungen
US20240299300A1 (en) * 2023-03-06 2024-09-12 Pedro P Perez Liposome vitamin c preparation
WO2025167728A1 (zh) * 2024-02-08 2025-08-14 湖南长星生物医药有限公司 靶向载体、靶向药物及制备方法与应用
CN119125393B (zh) * 2024-11-14 2025-06-24 南京恒远科技开发有限公司 二硬脂酰磷脂酰甘油钠有关物质的分析检测方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387410A (en) 1983-03-18 1995-02-07 Mallinckrodt, Inc. Method for enhancing magnetic resonance with compositions containing paramagnetic elements carried by liposomes
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
JPH0720857B2 (ja) * 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
IS1685B (is) 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
US5534241A (en) * 1993-07-23 1996-07-09 Torchilin; Vladimir P. Amphipathic polychelating compounds and methods of use
US6217849B1 (en) * 1993-09-29 2001-04-17 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents
US5716673A (en) * 1994-11-07 1998-02-10 Macronix Internationalco., Ltd. Spin-on-glass process with controlled environment
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US5833948A (en) 1995-06-15 1998-11-10 Bracco Research S.A. Blood-pool imaging composition comprising micelles containing a lipophilic chelating agent and a non-ionic surfactant
WO1998018501A2 (en) 1996-10-28 1998-05-07 Marsden, John, Christopher Improvements in or relating to diagnostic/therapeutic agents
US5827533A (en) * 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
GB9809084D0 (en) 1998-04-28 1998-06-24 Nycomed Imaging As Improvements in or relating to diagnostic/therapeutic agents
EP1105162A1 (de) * 1998-08-10 2001-06-13 Bracco Research S.A. Kombination eines positiven kernspinnresonenzkontrastmittels mit einem negativen kernspinnresonenzkontrastmittel
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
US6328988B1 (en) 1999-04-23 2001-12-11 Rutgers, The State University Of New Jersey Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules
AU2002248222B2 (en) 2000-12-23 2006-04-27 Dyax Corp. Fibrin binding polypeptides useful inter alia in medical imaging processes
WO2003084574A1 (en) 2002-03-01 2003-10-16 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
AU2003213730A1 (en) 2002-03-01 2003-09-16 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy

Also Published As

Publication number Publication date
WO2005117832A1 (en) 2005-12-15
DE602005010424D1 (de) 2008-11-27
CN1960707B (zh) 2012-11-14
CN1960707A (zh) 2007-05-09
EP1750671A1 (de) 2007-02-14
ES2313352T3 (es) 2009-03-01
US20070196284A1 (en) 2007-08-23
JP2008501667A (ja) 2008-01-24
JP4773430B2 (ja) 2011-09-14
US7749485B2 (en) 2010-07-06
EP1750671B1 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
DE602005010424D1 (de) Liposomale anordnung für die therapeutische und/oder diagnostische anwendung
BRPI0608297A2 (pt) composições de lipossomos
BRPI0508425A (pt) análogos de fosfolipìdeo como agentes diapêuticas e seus métodos
MX2020014107A (es) Uso de liposoma de mitoxantrona para tratar el linfoma no de hodgkin.
AR038605A1 (es) Uso de agentes para la manufactura de un medicamento para el tratamiento de inflamacion y composiciones para dicho tratamiento
FR15C0009I2 (fr) Compositions de gel phospholipide destinees a l'administration medicamenteuse et des methodes de traitement utilisant celles-ci
ME03019B (de) Pharmazeutische zusammensetzung von n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4- oxochinolin-3-carbonsäureamid und ihre verabreichung
BRPI0506305A (pt) artigos e métodos de tratamento da pele
BRPI0511235A (pt) preparado tópico e método para a administração transdérmica e localização de agentes terapêuticos
UY28662A1 (es) Agente endoparasiticida para administracion topica
ECSP077275A (es) Novedosos derivados de heteroarilsulfamida benzofusionados utiles como agentes anticonvulsivos
WO2007092432A3 (en) Liquid-filled nanodroplets for anti-cancer therapy
FR2869231B1 (fr) Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine
AR075413A1 (es) Composiciones y metodo para usar aminopiridinas metodo para tratar la esclerosis multiple
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
CO6311008A2 (es) Composicion farmaceutica que comprende un agente que activa las celulas t regulatorias cd4+cd25+
MX353964B (es) Agentes terapeuticos y usos de los mismos.
AR109263A2 (es) Composición que comprende moxidectina
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
PL1680128T3 (pl) Heksafosforan mio-inozytolu do stosowania miejscowego
WO2004071538A3 (en) Topical delivery of cosmetic agents
BRPI0518368A2 (pt) artigo absorvente descartÁvel tendo envoltàrios para as pernas e mÉtodo de fabricar o mesmo
BR0116972A (pt) Métodos e dispositivos para administração de substâncias na camada intradérmica da pele para absorção sistêmica
NI200800216A (es) Uso de compuestos peptídicos de tpo y composiciones farmacéuticas en el tratamiento de la anemia
WO2008109119A3 (en) Wnt compositions and methods of use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties